Lamivudine / Zidovudine ViiV (previously Lamivudine / Zidovudine GSK): Opinion on medicine for use outside EU
lamivudine / zidovudine
Table of contents
Overview
The opinion for Lamivudine / Zidovudine ViiV for use outside the European Union has been withdrawn at the request of the opinion holder.
Opinion details
| Product details | |
|---|---|
| Name of medicinal product |
Lamivudine / Zidovudine ViiV (previously Lamivudine / Zidovudine GSK)
|
| Agency opinion number |
H/W/672
|
| Opinion status |
Withdrawn opinion
|
| Active substance |
|
| International non-proprietary name (INN) or common name |
|
| Therapeutic area (MeSH) |
HIV Infections
|
| Anatomical therapeutic chemical (ATC) code |
J05AR01
|
| Publication details | |
|---|---|
| Opinion holder |
ViiV Healthcare UK Limited |
| Date of opinion |
17/11/2005
|
Product information
17/09/2015 Lamivudine / Zidovudine ViiV (previously Lamivudine / Zidovudine GSK) H-W-672-WS-0755
Contents
- Annex I - Summary of product characteristics
- Annex IIA - Manufacturer responsible for batch release
- Annex IIB - Recommendations to the opinion holder - conditions of use
- Annex IIIA - Labelling
- Annex IIIB - Package leaflet
Please note that the size of the above document can exceed 50 pages.
You are therefore advised to be selective about which sections or pages you wish to print.
Pharmacotherapeutic group
Antivirals for systemic use
Therapeutic indication
Lamivudine/zidovudine is indicated as part of antiretroviral combination therapy for the treatment of human immunodeficiency virus (HIV) infected adults and children.
Assessment history
-
List item
Lamivudine/Zidovudine ViiV : Lamivudine / Zidovudine GSK-H-W-672-II-0011 - Scientific discussion (PDF/699.04 KB)
First published: 28/04/2009
Last updated: 21/12/2015
EMEA/H/C/0672/II/0011 -
List item
Lamivudine/Zidovudine ViiV : Procedural steps taken and scientific information after opinion (PDF/350.66 KB)
First published: 28/04/2009
Last updated: 21/12/2015 -
List item
Lamivudine/Zidovudine ViiV : Procedural steps taken before opinion (PDF/211.48 KB)
First published: 28/04/2009
Last updated: 21/12/2015 -
List item
Lamivudine/Zidovudine ViiV : Scientific discussion (PDF/279.08 KB)
First published: 28/04/2009
Last updated: 21/12/2015 -
List item
Lamivudine/Zidovudine ViiV : All presentations (PDF/190.64 KB)
First published: 28/04/2009
Last updated: 21/12/2015 -
List item
Lamivudine/Zidovudine ViiV : Public statement - Cessation of manufacture (PDF/67.47 KB)
First published: 28/04/2009
Last updated: 21/12/2015
EMA/849940/2015